Upsher-Smith Laboratories, LLC (Upsher-Smith) today announced that it will attend the 2024 Child Neurology Society (CNS) Annual Meeting in San Diego, CA from November 11-14, 2024. Representatives from ...

Immunotherapy, which enhances the immune system's T cell response to eliminate cancer cells, has emerged as a key approach in ...

A CAR-T trial is one of several efforts that suggest there’s hope of treating the “worst imaginable childhood brain tumor,” ...

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

2024 /PRNewswire/ -- Abbisko today announced that the Phase 3 MANEUVER study evaluating pimicotinib in the treatment of tenosynovial giant cell tumor (TGCT) achieved statistically significant ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far ... effects on the nervous system -- which are already known to occur from other CAR T-cell therapies -- and how much ...

Nov. 12, 2024 — Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this aggressive tumor permanently disappear. The tumor cells ...

It is alleged that Zappa abused the infant, who is listed in critical condition at an area hospital with a significant brain bleed. Bruising was also found on the baby’s head, neck and chest ...

Astrocytes — named for their star-like shape — are a type of brain cell that protect nerves and are vital for processing information. Studies show that these cells reduce in quantity as ...

In a trial with 11 patients with midline diffuse glioma, 9 showed benefits from the cellular therapy. In one case, the tumor ...

A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients. View on ...